The new system is designed to manage all aspects of Marken’s global depot network including: receipt of clinical supplies and kits, dispatches, returns, warehouse movements and QA releases.

Solo is a secure, validated, web-based system which is fully accessible to Marken’s clients on a 24/7 basis from any location in the world. Additionally, Marken has designed Solo to integrate with multiple client-directed IXR (Interactive Reporting) systems.

Frank Wright, interim president for clinical trials distribution at Marken, said: "We are pleased to offer this new system to our growing number of pharmaceutical clients. Solo is a very unique and fit for purpose application which incorporates all of our client’s requirements for remote storage and distribution of their clinical trial supplies. We are also excited to be launching Solo as we manage an increasing number of depots around the world."

Solo is purpose-built to allow a high degree of customization supporting the dynamic needs of Marken’s pharmaceutical client base.

Wes Wheeler, CEO of Marken, said: "We welcome the pharmaceutical industry to discuss their global distribution needs for pharmaceutical logistics and supply chain management with us.

"We are uniquely positioned to grow with the industry’s need for management of time critical, temperature critical and complex shipments of their clinical supplies. We are committed to providing fully validated facilities in strategic centers around the world from which clinical trials can be managed."

Have your say and discuss with your peers on the InfoGrok community.

Participate by posting your comments now.